Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name GSK3359609
Trade Name
Synonyms GSK609|GSK-3359609|GSK 3359609|feladilimab
Drug Descriptions

GSK3359609 is an antibody that binds to the inducible T-cell co-stimulator (ICOS, CD278), resulting in stimulation of T-cell proliferation and immune response (AACR Annual Meeting 2019, Abstract CT166, PMID: 31847708).

CAS Registry Number NA
NCIT ID C126804


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
belantamab mafodotin-blmf + GSK3359609 GSK3359609 belantamab mafodotin-blmf 0 1
Carboplatin + Fluorouracil + GSK3359609 + Pembrolizumab Carboplatin Fluorouracil GSK3359609 Pembrolizumab 0 1
Cisplatin + Fluorouracil + GSK3359609 + Pembrolizumab Cisplatin Fluorouracil GSK3359609 Pembrolizumab 0 1
Docetaxel + GSK3359609 Docetaxel GSK3359609 0 1
GSK3359609 GSK3359609 0 1
GSK3359609 + Pembrolizumab GSK3359609 Pembrolizumab 0 2
GSK3359609 + Tremelimumab GSK3359609 Tremelimumab 0 1

Additional content available in CKB BOOST